Mimi Guebre‐Xabier

2.1k total citations
24 papers, 858 citations indexed

About

Mimi Guebre‐Xabier is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Mimi Guebre‐Xabier has authored 24 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Mimi Guebre‐Xabier's work include Immunotherapy and Immune Responses (6 papers), Respiratory viral infections research (5 papers) and Immune Cell Function and Interaction (5 papers). Mimi Guebre‐Xabier is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Respiratory viral infections research (5 papers) and Immune Cell Function and Interaction (5 papers). Mimi Guebre‐Xabier collaborates with scholars based in United States, Ethiopia and United Kingdom. Mimi Guebre‐Xabier's co-authors include Robert Schwenk, Gregory M. Glenn, Larry Ellingsworth, Urszula Krzych, Scott A. Hammond, Anna Mae Diehl, Shiqi Yang, Jianmei Yu, Gale Smith and Nita Patel and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Hepatology.

In The Last Decade

Mimi Guebre‐Xabier

22 papers receiving 806 citations

Peers

Countries citing papers authored by Mimi Guebre‐Xabier

Since Specialization

Citations

This map shows the geographic impact of Mimi Guebre‐Xabier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mimi Guebre‐Xabier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mimi Guebre‐Xabier more than expected).

Fields of papers citing papers by Mimi Guebre‐Xabier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mimi Guebre‐Xabier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mimi Guebre‐Xabier. The network helps show where Mimi Guebre‐Xabier may publish in the future.

Co-authorship network of co-authors of Mimi Guebre‐Xabier

This figure shows the co-authorship network connecting the top 25 collaborators of Mimi Guebre‐Xabier. A scholar is included among the top collaborators of Mimi Guebre‐Xabier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mimi Guebre‐Xabier. Mimi Guebre‐Xabier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines 2025 ·Cell Reports ·Sandhya Bangaru, Abigail M. Jackson, Jeffrey Copps, Monica L. Fernández‐Quintero, Jonathan L. Torres, Sara T. Richey, Bartek Nogal, Leigh M. Sewall, Alba Torrents de la Peña, (unknown), Mimi Guebre‐Xabier, Bethany Girard, Rituparna Das, Kizzmekia S. Corbett, Robert A. Seder, Barney S. Graham, Darin K. Edwards, Nita Patel, Gale Smith, Andrew B. Ward	0
2	Single-dose avian influenza A(H5N1) Clade 2.3.4.4b hemagglutinin–Matrix-M® nanoparticle vaccine induces neutralizing responses in nonhuman primates 2025 ·Nature Communications ·Nita Patel, (unknown), (unknown), Rhonda Flores, (unknown), Mimi Guebre‐Xabier, Haixia Zhou, Bin Zhou, Kelsey Jacobson, Desheng Jiang, Xiaoyun Bai, Rafia Khatoon, (unknown), James A. Norton, (unknown), (unknown), (unknown), Filip Dubovsky, Gale Smith	0
3	Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters 2024 ·Journal of Virology ·Traci L. Bricker, Astha Joshi, Nadia Soudani, Suzanne M. Scheaffer, Nita Patel, Mimi Guebre‐Xabier, Gale Smith, Michael Diamond, Adrianus C. M. Boon	4
4	XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants 2023 ·Scientific Reports ·Nita Patel, Jessica F. Trost, Mimi Guebre‐Xabier, Haixia Zhou, (unknown), Desheng Jiang, Zhaohui Cai, Mingzhu Zhu, (unknown), (unknown), Raburn M. Mallory, Raj Kalkeri, Filip Dubovsky, Gale Smith	36
5	NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge 2020 ·Vaccine ·Mimi Guebre‐Xabier, Nita Patel, Jing-Hui Tian, Bin Zhou, Sonia Maciejewski, (unknown), Alyse D. Portnoff, Michael J. Massare, Matthew B. Frieman, Pedro A. Piedra, Larry Ellingsworth, Gregory M. Glenn, Gale Smith	149
6	Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection 2019 ·Vaccine ·Nita Patel, (unknown), Jing-Hui Tian, Mimi Guebre‐Xabier, Hanxin Lu, Haixia Zhou, Ernest L. Maynard, Daniel R. Scott, Larry Ellingsworth, Gregory M. Glenn, Gale Smith	28
7	Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challenge 2019 ·Vaccine ·Charles Welliver, James F. Papin, (unknown), (unknown), Jing-Hui Tian, Hanxin Lu, Mimi Guebre‐Xabier, David C. Flyer, Michael J. Massare, Greg Glenn, Larry Ellingsworth, Gale Smith	9
8	Evaluation of transcutaneous immunization as a delivery route for an enterotoxigenic E. coli adhesin-based vaccine with CfaE, the colonization factor antigen 1 (CFA/I) tip adhesin 2019 ·Vaccine ·Julianne E. Rollenhagen, (unknown), Aisling O’Dowd, S. Poole, (unknown), Mimi Guebre‐Xabier, Larry Ellingsworth, Michael G. Prouty, Greg Glenn, Stephen J. Savarino	15
9	Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge 2018 ·Vaccine ·Brian E. Gilbert, Nita Patel, Hanxin Lu, Ye Liu, Mimi Guebre‐Xabier, Pedro A. Piedra, Gregory M. Glenn, Larry Ellingsworth, Gale Smith	20
10	Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs 2015 ·Vaccine ·Gregory M. Glenn, Louis Fries, Gale Smith, Eloi Kpamegan, Hanxin Lu, Mimi Guebre‐Xabier, Somia P. Hickman, David C. Flyer	21
11	Immunostimulant Patch Enhances Immune Responses to Influenza Virus Vaccine in Aged Mice 2004 ·Journal of Virology ·Mimi Guebre‐Xabier, Scott A. Hammond, Larry Ellingsworth, Gregory M. Glenn	37
12	Induction of Protective Immunity against Lethal Anthrax Challenge with a Patch 2004 ·The Journal of Infectious Diseases ·Richard T. Kenney, Jianmei Yu, Mimi Guebre‐Xabier, Sarah A. Frech, Adam Lambert, Brigitte Heller, Larry Ellingsworth, (unknown), E. Diane Williamson, (unknown)	57
13	Protracted Protection to Plasmodium berghei Malaria Is Linked to Functionally and Phenotypically Heterogeneous Liver Memory CD8+ T Cells 2003 ·The Journal of Immunology ·(unknown), Robert Schwenk, (unknown), Mimi Guebre‐Xabier, Jackie Williams, Urszula Krzych	92
14	The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites 2000 ·Immunological Reviews ·Urszula Krzych, Robert Schwenk, Mimi Guebre‐Xabier, Peifang Sun, Dupeh R. Palmer, Katherine White, (unknown)	48
15	Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: Potential mechanism for sensitization to liver damage 2000 ·Hepatology ·Mimi Guebre‐Xabier, Shiqi Yang, (unknown), Robert Schwenk, (unknown), Anna Mae Diehl	163
16	Memory phenotype CD8+ T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites 1999 ·European Journal of Immunology ·Mimi Guebre‐Xabier, Robert Schwenk, Urszula Krzych	5
17	Memory phenotype CD8+ T cells persist in livers of mice protected against malaria by immunization with attenuatedPlasmodium bergheisporozoites 1999 ·European Journal of Immunology ·Mimi Guebre‐Xabier, Robert Schwenk, Urszula Krzych	48
18	Early detection of rifampin in human nerve tissue after an oral dose of 600 milligrams 1995 ·Antimicrobial Agents and Chemotherapy ·Mimi Guebre‐Xabier, Emer Shannon, (unknown), (unknown), D. Frommel	1
19	Loss of viability ofMycobacterium lepraeisolated from nasal secretions of lepromatous leprosy patients following daily rifampicin and DDS therapy 1993 ·Leprosy Review ·(unknown), Mimi Guebre‐Xabier	1
20	Sero-epidemiological survey of Toxoplasma gondii infection in Ethiopia. 1993 ·PubMed ·Mimi Guebre‐Xabier, (unknown), (unknown), Abraha Hailu, (unknown), (unknown), D. Frommel	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact